209
Participants
Start Date
August 23, 2022
Primary Completion Date
March 9, 2023
Study Completion Date
December 26, 2027
Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine
Liquid solution for injection Intramuscular
Investigational Site Number : 3480002, Budapest
Investigational Site Number : 3480001, Budapest
Investigational Site Number : 3480005, Miskolc
Investigational Site Number : 3480006, Székesfehérvár
Investigational Site Number : 7240006, Santiago de Compostela
Investigational Site Number : 2460010, Turku
Investigational Site Number : 2760015, Hamburg
Investigational Site Number : 7240002, Madrid
Investigational Site Number : 7240001, Madrid
Investigational Site Number : 2460003, Pori
Investigational Site Number : 2460008, Tampere
Investigational Site Number : 7240003, Seville
Investigational Site Number : 2760002, Mönchengladbach
Investigational Site Number : 2760008, Mönchengladbach
Investigational Site Number : 2760001, Bramsche
Investigational Site Number : 2460004, Kokkola
Investigational Site Number : 2760011, Bönnigheim
Investigational Site Number : 2760007, Bretten
Investigational Site Number : 2760006, Schönau
Investigational Site Number : 2460007, Oulu
Investigational Site Number : 2760003, Tauberbischofsheim
Investigational Site Number : 2760004, Erfurt
Investigational Site Number : 2460009, Espoo
Investigational Site Number : 2460001, Helsinki
Investigational Site Number : 2460006, Helsinki
Investigational Site Number : 2460002, Järvenpää
Sanofi Pasteur, a Sanofi Company
INDUSTRY